Your Top 50 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial

Toni K. Choueiri, Konstantin Penkov, Hiroji Uemura, Matthew T. Campbell, Sumanta Kumar Pal, Christian Kollmannsberger and 21 more

Rank
39 of 3,853
Percentile
top 1.1%
Where
Annals of Oncology, 2024
Citations
64

From the 2024 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.